en

PRODUCT DETAIL

ORENCIA 250 mg prášok na koncentrát na infúzny roztok

Code 43231
MA number EU/1/07/389/002
Product Form: plc ifc 2x250 mg (2x liek.inj.skl.+2x striek.inj.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AA Selective immunosuppressants
L04AA24 Abatacept
Shelf life: 36
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application
MA issued: 21.05.2007
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 07.03.2023
eu-flag.png sk-flag.png